Using PF-MOUTH GELTM for Sore or Painful Tongue Improved Symptoms and Stabilized Dryness and Trapping of Food: A Case Report
DOI:
https://doi.org/10.17140/DOJ-7-143Keywords:
Tongue, Fucoidan, Inflammation, Treatment, GelAbstract
We describe herein the case of a 72-year-old woman with persistent and symptomatic sore or painful tongue (SPT) treated using
PF-MOUTH GELTM (PF-Gel; Daiichi-Sangyo, Osaka, Japan), which includes 30% fucoidan and 0.75% sword bean. PF-MOUTH
GELTM was applied to the tongue and kept in place for 3-min. Application was performed twice a day (morning and evening)
for 3-months, and resulted in marked improvement of symptomatic sore or painful tongue. Because only one case was reported
in this study, clinical trials are required to confirm the efficacy and safety of topical PF-MOUTH GELTM for the treatment of
symptomatic sore or painful tongue.
References
Kylin H. Biochemistry of seaweeds. Z Physiol Chem. 1918; 101: 236-245.
Berteau O, Mulloy B. Sulfated fucans, fresh perspectives: struc-tures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharide. Glycobiology. 2003; 13: 29-40. doi: 10.1093/glycob/cwg058
Ribeiro AC, Vieira RP, Mourao PAS, Muloy B. A sulfated alpha--L-fucan from sea cucumber. Carbohydr Res. 1994; 255: 225-240. doi: 10.1016/s0008-6215(00)90981-9
Teruya K, Kusumoto Y, Eto H, Nakamichi N, Shirahata S. Se-lective suppression of cell growth and programmed cell death-li-gand 1 expression in HT 1080 fibrosarcoma cells by low molecular weight fucoidan extract. Mar Drugs. 2019; 17(7): 421. doi: 10.3390/ md17070421
Takahashi H, Kawaguchi M, Kitamura K, Narumiya S, Kawa-mura M, Tengan I, et al. An exploratory study on the anti-in-flammatory effects of fucoidan in relation to quality of life in ad-vanced cancer patients. Integr Cancer Ther. 2018; 17(2): 282-291. doi: 10.1177/1534735417692097
Tsubura S, Waki Y, Tsubura T. Recurrent aphthous stomatitis treated with fucoidan. J Cranio-Maxillary Dis. 2012; 1(2): 105-108. doi: 10.4103/2278-9588.105699
Tsubura S, Suzuki A. Case report using 4% fucoidan cream for recurrent oral herpes labialis: Patient symptoms markedly impro-ved in terms of time to healing and time to loss of discomfort.
Oka S, Okabe M, Tsubura S, Mikami M, Imai A. Properties of fucoidans beneficial to oral healthcare. Odontology. 2020; 108(1): 34- Submit your article to this journal | https://openventio.org/submit-manuscript/ Case Report | Volume 7 | Number 1| Tsubura S et al 43. doi: 10.1007/s10266-019-00437-3
Shulman JD, Beach MM, Rivera-Hidalgo F. The prevalence of oral mucosal lesions in U.S. adults: Data from the Third Natio-nal Health and Nutrition Examination Survey, 1988-1994. J Am Dent Assoc. 2004; 135(9): 1279-1286. doi: 10.14219/jada.archi-ve.2004.0403
Siddhanta AK, Murthy ASK. Bioactive polysaccharides from marine brown algae (Phaeophyceae). J Indian Chem Soc. 2001; 78: 431- 437.
Aisa Y. Fucoidan induces apoptosis of human HS-sultan ce-lls accompanied by activation of caspase-3 and down-regulation of ERK pathways. Am J Hematol. 2005; 78: 7-14. doi: 10.1002/ ajh.20182
Moon HJ, Lee SH, Ku MJ, Yu BC, Jeon MJ, Jeong SH, et al. Fucoidan inhibits UVB-induced MMP-1 promoter expression and down regulation of type I procollagen synthesis in human skin fibroblasts. Eur J Dermatol. 2009; 19: 129-134. doi: 10.1684/ ejd.2008.0611
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Dentistry (DOJ) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
